CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
Page 2 of 5 · 99 filings